Jessica Nye, PhD

Researchers examined the efficacy and safety of molnupiravir as intra-household post-exposure prophylaxis against COVID-19 infection.

A study was conducted to determine the relationship between adherence to PAP therapy and health care utilization in patients with OSA and HFrEF.

A study was conducted to determine the effect of hypertension in adolescence on risk for stroke in young adults.

Researchers examined the epidemiology and clinical outcomes of sporadic health care-associated respiratory syncytial virus infection in children.

Researchers evaluated the incidence of catheter-associated bloodstream infections among patients hospitalized with COVID-19 infection.

Researchers sought to determine whether polysomnographic sleep parameters are associated with neuroimaging biomarkers of cerebrovascular disease related to white matter integrity in older adults with OSA.

Researchers examined the relationship between long-term antibiotic exposure and the risk for lung cancer.

Researchers studied the association between sleep patters and risk for new-onset gout.

Researchers assessed primary safety and virologic efficacy outcomes of 3 commonly used antiretroviral therapy regimens during pregnancy.

Researchers examined the benefits of routine immunologic testing among children with severe bacterial infections.

Researchers evaluated immune responses to viral vectored-, mRNA-, and protein-based COVID-19 vaccine platforms across homologous and heterologous priming combinations.

A study was conducted to examine the safety and efficacy of balloon pulmonary angioplasty for treatment of nonoperable CTEPH in patients with COPD.

In an international case-control study, researchers evaluated the association between a wide range of sleep disturbance symptoms and risk for acute stroke.

Researchers evaluated the efficacy and safety of oral semaglutide 7 and 14 mg for type 2 diabetes.

A meta-analysis assessed the effects of opioids on breathlessness in patients with advanced heart failure.

Researchers sought to report the rate of persistent smoking after ischemic stroke and the association between smoking status and major cardiovascular events.

The risk of developing interstitial lung disease with different biologic or targeted synthetic DMARDs was assessed among patients with rheumatoid arthritis.

Researchers quantified the performance of diagnostic testing methods for respiratory syncytial virus and assessed the use of multiple specimen types on detection rates.

Researchers evaluated whether there is an association between remdesivir dosing and time to bradycardia among patients hospitalized with COVID-19 infection.

Researchers compared the safety and efficacy of monoclonal antibody treatments for protection against respiratory syncytial virus infection among infants and children.

Researchers studied the trajectories of pulmonary arterial pressure, and the clinical phenotype associated with each trajectory, in patients with systemic sclerosis.

Researchers evaluated access to tuberculosis diagnostics among hospitalized patients with HIV infection before vs during the COVID-19 pandemic.

Researchers evaluated protection conferred by 2- and 3-doses of the COVID-19 BNT162b2 vaccine among adolescents during the Delta and Omicron periods.

Researchers evaluated the demographic, clinical, and laboratory characteristics of patients hospitalized with COVID-19 infection.

Researchers evaluated the effects of remdesivir on mortality risk among patients hospitalized with COVID-19 outside of the clinical trial setting.

Researchers examined the association between pneumococcal carriage and COVID-19 infection.

Researchers evaluated risk factors associated with persistent COVID-19 symptoms 1 year after the acute phase of infection.

Researchers assessed the risk for secondary monkeypox transmission among individuals who were exposed to the first US patient diagnosed with the infection.

Researchers evaluated the effect of influenza vaccination on reducing antibiotic prescription outcomes for adults diagnosed with influenza-like illness.

Researchers evaluated whether finerenone treatment protects against pneumonia and COVID-19 in patients with chronic kidney disease and type 2 diabetes.